{
    "raw_data": {
        "nct_id": "NCT00319748",
        "official_title": "Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers",
        "criteria": {
            "raw_text": "Inclusion Criteria:\n\n* Adequate performance status:\n\n  * Breast - Karnofsky score \\> 50;\n  * Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2\n* If female and of childbearing potential, are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation.\n* Normal organ function within 14 days of study entry\n* Diagnosis of one of the following malignancies:\n\n  * Metastatic breast cancer (BR)\n  * Metastatic ovarian cancer (OV)\n  * Metastatic endometrial cancer (EM)\n  * Metastatic cervical cancer (CX)\n\nBreast Cancer Inclusion Criteria:\n\n* Measurable metastatic disease (\\>1cm) in at least one site other than bone-only\n* Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease\n* Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.\n\nOvarian Cancer Inclusion Criteria:\n\n* Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)\n* Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).\n* Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.\n\nEndometrial Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens\n\nCervical Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens.\n\nExclusion Criteria:\n\n* Had/have the following prior/concurrent therapy:\n\n  * Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)\n  * Investigational drugs/agents within 14 days of first dose of 852A\n  * Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)\n  * Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions\n  * Radiotherapy within 3 weeks of the first dose of 852A\n  * Hematopoietic cell transplantation within 4 weeks of first dose of 852A\n  * Evidence of active infection within 3 days of first dose of 852A\n  * Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)\n  * Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication\n  * History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk\n  * Uncontrolled intercurrent or chronic illness\n  * Active autoimmune disease requiring immunosuppressive therapy within 30 days\n  * Active coagulation disorder not controlled with medication\n  * Pregnant or lactating\n  * Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated\n  * Any history of brain metastases or any other active central nervous system (CNS) disease"
        }
    },
    "structurized": {
        "raw_text": "Inclusion Criteria:\n\n* Adequate performance status:\n\n  * Breast - Karnofsky score > 50;\n  * Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2\n* If female and of childbearing potential, are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation.\n* Normal organ function within 14 days of study entry\n* Diagnosis of one of the following malignancies:\n\n  * Metastatic breast cancer (BR)\n  * Metastatic ovarian cancer (OV)\n  * Metastatic endometrial cancer (EM)\n  * Metastatic cervical cancer (CX)\n\nBreast Cancer Inclusion Criteria:\n\n* Measurable metastatic disease (>1cm) in at least one site other than bone-only\n* Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease\n* Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.\n\nOvarian Cancer Inclusion Criteria:\n\n* Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)\n* Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).\n* Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.\n\nEndometrial Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens\n\nCervical Cancer Inclusion Criteria:\n\n* Measurable metastatic disease\n* Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens.\n\nExclusion Criteria:\n\n* Had/have the following prior/concurrent therapy:\n\n  * Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)\n  * Investigational drugs/agents within 14 days of first dose of 852A\n  * Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)\n  * Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions\n  * Radiotherapy within 3 weeks of the first dose of 852A\n  * Hematopoietic cell transplantation within 4 weeks of first dose of 852A\n  * Evidence of active infection within 3 days of first dose of 852A\n  * Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)\n  * Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication\n  * History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk\n  * Uncontrolled intercurrent or chronic illness\n  * Active autoimmune disease requiring immunosuppressive therapy within 30 days\n  * Active coagulation disorder not controlled with medication\n  * Pregnant or lactating\n  * Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated\n  * Any history of brain metastases or any other active central nervous system (CNS) disease",
        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
        "category_reasoning": "The criterion includes multiple inclusion and exclusion criteria that are logically connected and can be separated into distinct questions. It involves hierarchical criteria for different cancer types and specific conditions for inclusion and exclusion.",
        "overall_thoughts": "The criterion is well-structured, covering a comprehensive set of inclusion and exclusion criteria for a clinical trial involving multiple cancer types. It specifies performance status, organ function, and specific cancer diagnoses for inclusion, as well as detailed exclusion criteria related to prior therapies and health conditions.",
        "logical_operator": "AND",
        "criterions": [
            {
                "raw_text": "Adequate performance status: * Breast - Karnofsky score > 50; * Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion specifies different performance status requirements for different types of cancer, which can be separated into distinct questions based on the type of cancer.",
                "overall_thoughts": "The criterion is well-structured, specifying performance status requirements for different cancer types, which makes it a compound criterion.",
                "logical_operator": "AND",
                "criterions": [
                    {
                        "raw_text": "Breast - Karnofsky score > 50",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition related to the Karnofsky score, which is a standard measure of a patient's functional status.",
                        "overall_thoughts": "This criterion is straightforward, specifying that the patient must have a Karnofsky score greater than 50, which indicates a certain level of functional ability.",
                        "root_term": "Karnofsky score",
                        "qualifiers": [
                            "> 50"
                        ],
                        "relation_type": "greater than",
                        "target": [
                            {
                                "answer": "greater than 50",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "The Karnofsky score is used to quantify cancer patients' general well-being and activities of daily life."
                        ]
                    },
                    {
                        "raw_text": "Ovarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves multiple conditions (ovarian, endometrial, or cervical) and a performance score requirement, which can be separated into distinct questions.",
                        "overall_thoughts": "The criterion specifies types of cancer and a performance score threshold, indicating eligibility based on both cancer type and functional status.",
                        "root_term": "Gynecologic Oncology Group (GOG) performance score",
                        "qualifiers": [
                            "≤2"
                        ],
                        "relation_type": "requirement",
                        "target": [
                            {
                                "answer": "ovarian cancer",
                                "dependent_criterion": null
                            },
                            {
                                "answer": "endometrial cancer",
                                "dependent_criterion": null
                            },
                            {
                                "answer": "cervical cancer",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "The GOG performance score is used to assess the functional status of patients in gynecologic oncology."
                        ]
                    }
                ]
            },
            {
                "raw_text": "If female and of childbearing potential, are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation.",
                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                "category_reasoning": "The criterion is hierarchical because it starts with a condition (being female and of childbearing potential) and then specifies an additional requirement (willingness to use contraception) if the condition is met.",
                "overall_thoughts": "This criterion is designed to ensure that female participants who could become pregnant are taking steps to prevent pregnancy during the study, which is a common requirement in clinical trials to avoid potential harm to a fetus.",
                "parent_criterion": {
                    "raw_text": "If female and of childbearing potential",
                    "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                    "category_reasoning": "The criterion involves two separate conditions: being female and being of childbearing potential. These are distinct criteria that are combined using a logical operator.",
                    "overall_thoughts": "This criterion is a compound criterion because it combines two separate conditions that must both be met. It is common in clinical trials to specify criteria related to gender and reproductive potential, especially when considering the safety and efficacy of treatments.",
                    "logical_operator": "AND",
                    "criterions": [
                        {
                            "raw_text": "female",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is a simple statement that specifies a gender requirement for the trial, which can be answered with a yes or no.",
                            "overall_thoughts": "This criterion specifies that the trial is only open to female participants.",
                            "root_term": "gender",
                            "qualifiers": [],
                            "relation_type": "equals",
                            "target": [
                                {
                                    "answer": "female",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": []
                        },
                        {
                            "raw_text": "of childbearing potential",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no regarding whether a participant is of childbearing potential.",
                            "overall_thoughts": "This criterion is used to determine if a participant is capable of becoming pregnant, which is often relevant for trials involving medications that could affect pregnancy.",
                            "root_term": "childbearing potential",
                            "qualifiers": [
                                "of"
                            ],
                            "relation_type": "is",
                            "target": [
                                {
                                    "answer": "yes",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "This criterion is often used to assess eligibility for trials where pregnancy could be a risk due to the intervention."
                            ]
                        }
                    ]
                },
                "child_criterion": {
                    "raw_text": "are willing to use adequate contraception (hormonal, barrier method, abstinence) prior to study entry and for the duration of study participation",
                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                    "category_reasoning": "The criterion is a straightforward requirement regarding the use of contraception, which can be answered with a simple yes or no.",
                    "overall_thoughts": "This criterion specifies the requirement for participants to use contraception during the study period, which is a common requirement in clinical trials to prevent pregnancy and ensure participant safety.",
                    "root_term": "use adequate contraception",
                    "qualifiers": [
                        "willing",
                        "prior to study entry",
                        "for the duration of study participation"
                    ],
                    "relation_type": "are willing to",
                    "target": [
                        {
                            "answer": "yes",
                            "dependent_criterion": null
                        }
                    ],
                    "additional_information": [
                        "Types of contraception include hormonal, barrier method, abstinence."
                    ]
                },
                "additional_information": [
                    "The criterion is focused on ensuring safety and compliance with study protocols regarding pregnancy prevention."
                ]
            },
            {
                "raw_text": "Normal organ function within 14 days of study entry",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion specifies a single condition that can be verified with a straightforward assessment of organ function within a specified timeframe.",
                "overall_thoughts": "This criterion is straightforward, requiring participants to have normal organ function within a specific timeframe before entering the study.",
                "root_term": "organ function",
                "qualifiers": [
                    "normal",
                    "within 14 days of study entry"
                ],
                "relation_type": "has",
                "target": [
                    {
                        "answer": "normal",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "The criterion implies a check of organ function status close to the time of study entry."
                ]
            },
            {
                "raw_text": "Diagnosis of one of the following malignancies: * Metastatic breast cancer (BR) * Metastatic ovarian cancer (OV) * Metastatic endometrial cancer (EM) * Metastatic cervical cancer (CX)",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion lists multiple specific types of metastatic cancers, any one of which would satisfy the eligibility requirement. This makes it a compound criterion as it involves multiple options connected by an OR logical operator.",
                "overall_thoughts": "This criterion is well-structured for a clinical trial, as it clearly specifies the types of metastatic cancers that are eligible, allowing for straightforward inclusion based on diagnosis.",
                "logical_operator": "OR",
                "criterions": [
                    {
                        "raw_text": "Metastatic breast cancer (BR)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a straightforward statement about a specific medical condition, which can be answered with a yes or no.",
                        "overall_thoughts": "This criterion specifies a condition related to the patient's cancer status, which is a common type of eligibility criterion in clinical trials.",
                        "root_term": "breast cancer",
                        "qualifiers": [
                            "metastatic"
                        ],
                        "relation_type": "condition",
                        "target": [
                            {
                                "answer": "true",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "BR is an abbreviation for breast cancer."
                        ]
                    },
                    {
                        "raw_text": "Metastatic ovarian cancer (OV)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition related to the presence of metastatic ovarian cancer, which can be answered with a yes or no.",
                        "overall_thoughts": "This criterion is straightforward as it specifies a condition related to the presence of a specific type of cancer.",
                        "root_term": "ovarian cancer",
                        "qualifiers": [
                            "metastatic"
                        ],
                        "relation_type": "presence",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "OV is an abbreviation for ovarian cancer."
                        ]
                    },
                    {
                        "raw_text": "Metastatic endometrial cancer (EM)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition related to the presence of metastatic endometrial cancer, which can be answered with a yes or no.",
                        "overall_thoughts": "This criterion is straightforward, specifying the presence of metastatic endometrial cancer as a condition for eligibility.",
                        "root_term": "endometrial cancer",
                        "qualifiers": [
                            "metastatic"
                        ],
                        "relation_type": "presence",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Metastatic cervical cancer (CX)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a straightforward statement about the presence of a specific type of cancer, which can be answered with a yes or no.",
                        "overall_thoughts": "This criterion specifies a condition related to the type and stage of cancer, which is a common eligibility criterion in clinical trials.",
                        "root_term": "cervical cancer",
                        "qualifiers": [
                            "metastatic"
                        ],
                        "relation_type": "presence",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "CX is an abbreviation for cervical cancer."
                        ]
                    }
                ]
            },
            {
                "raw_text": "Breast Cancer Inclusion Criteria:\n\n* Measurable metastatic disease (>1cm) in at least one site other than bone-only\n* Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease\n* Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion is composed of multiple distinct conditions that need to be satisfied for inclusion, each of which can be considered separately.",
                "overall_thoughts": "The criterion is well-structured and clearly outlines multiple conditions for inclusion in the trial, focusing on measurable disease, previous treatment responses, and specific therapy progressions.",
                "logical_operator": "AND",
                "criterions": [
                    {
                        "raw_text": "Measurable metastatic disease (>1cm) in at least one site other than bone-only",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion specifies two conditions: having measurable metastatic disease greater than 1cm and that it must be in a site other than bone-only. These can be separated into distinct questions, making it a compound criterion.",
                        "overall_thoughts": "The criterion is clear in specifying the need for measurable metastatic disease and excluding bone-only sites, which are common considerations in clinical trials for metastatic conditions.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Measurable metastatic disease (>1cm)",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition that can be directly assessed: the presence of measurable metastatic disease larger than 1 cm.",
                                "overall_thoughts": "This criterion is straightforward, focusing on the presence of metastatic disease that is measurable and exceeds a certain size threshold.",
                                "root_term": "metastatic disease",
                                "qualifiers": [
                                    "measurable",
                                    "(>1cm)"
                                ],
                                "relation_type": "presence",
                                "target": [
                                    {
                                        "answer": "true",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "The criterion specifies a size threshold for the metastatic disease, indicating it must be greater than 1 cm to qualify."
                                ]
                            },
                            {
                                "raw_text": "in at least one site other than bone-only",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a condition that can be answered with a simple yes or no, regarding the presence of disease in sites other than bone.",
                                "overall_thoughts": "This criterion is straightforward, specifying that the disease must be present in at least one site other than bone. It is a simple inclusion/exclusion criterion.",
                                "root_term": "site",
                                "qualifiers": [
                                    "at least one",
                                    "other than bone-only"
                                ],
                                "relation_type": "presence",
                                "target": [
                                    {
                                        "answer": "present",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            }
                        ]
                    },
                    {
                        "raw_text": "Progression on or failure to respond to at least one previous chemotherapy regimen for metastatic disease",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: progression on a chemotherapy regimen and failure to respond to a chemotherapy regimen. These can be considered as separate questions regarding the patient's treatment history.",
                        "overall_thoughts": "The criterion is clear in specifying the conditions under which a patient would be eligible, focusing on their response to previous chemotherapy regimens for metastatic disease.",
                        "root_term": "chemotherapy regimen",
                        "qualifiers": [
                            "previous",
                            "for metastatic disease"
                        ],
                        "relation_type": "progression or failure to respond",
                        "target": [
                            {
                                "answer": "at least one",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "The criterion is specific to patients with metastatic disease."
                        ]
                    },
                    {
                        "raw_text": "Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive, and/or with trastuzumab if HER2-neu positive. If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves multiple conditions related to progression on prior therapies and receptor status, which can be separated into distinct questions regarding hormonal therapy, trastuzumab therapy, and chemotherapy regimen.",
                        "overall_thoughts": "This criterion specifies conditions for progression on prior therapies based on receptor status and requires additional chemotherapy if progression occurred only through hormone or trastuzumab therapy. It involves multiple logical conditions and dependencies.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Progression on prior therapy with a hormonal agent if estrogen receptor or progesterone receptor positive.",
                                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                                "category_reasoning": "The criterion is hierarchical because it has a parent condition (progression on prior therapy with a hormonal agent) that is further specified by a child condition (if estrogen receptor or progesterone receptor positive). The child condition adds an additional layer of specificity to the parent condition.",
                                "overall_thoughts": "This criterion is structured to first identify patients who have progressed on hormonal therapy and then further refines the group to those with specific receptor positivity, making it a clear hierarchical criterion.",
                                "parent_criterion": {
                                    "raw_text": "Progression on prior therapy with a hormonal agent",
                                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                    "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, indicating whether there has been progression on prior therapy with a hormonal agent.",
                                    "overall_thoughts": "This criterion is clear and specific, focusing on the progression of disease during or after treatment with a hormonal agent.",
                                    "root_term": "Progression",
                                    "qualifiers": [
                                        "on prior therapy with a hormonal agent"
                                    ],
                                    "relation_type": "on",
                                    "target": [
                                        {
                                            "answer": "Yes",
                                            "dependent_criterion": null
                                        }
                                    ],
                                    "additional_information": []
                                },
                                "child_criterion": {
                                    "raw_text": "if estrogen receptor or progesterone receptor positive",
                                    "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                                    "category_reasoning": "The criterion involves two separate conditions: being estrogen receptor positive and being progesterone receptor positive. These are connected by the logical operator 'OR', indicating that either condition can satisfy the criterion.",
                                    "overall_thoughts": "This criterion is a straightforward compound criterion involving two receptor statuses that are commonly evaluated in clinical trials for hormone receptor-positive breast cancer.",
                                    "logical_operator": "OR",
                                    "criterions": [
                                        {
                                            "raw_text": "estrogen receptor positive",
                                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                            "category_reasoning": "The criterion is a simple statement that can be answered with a yes or no, indicating whether the estrogen receptor status is positive.",
                                            "overall_thoughts": "This criterion specifies a molecular characteristic of the cancer, which is commonly used in clinical trials to determine eligibility based on hormone receptor status.",
                                            "root_term": "estrogen receptor",
                                            "qualifiers": [
                                                "positive"
                                            ],
                                            "relation_type": "status",
                                            "target": [
                                                {
                                                    "answer": "positive",
                                                    "dependent_criterion": null
                                                }
                                            ],
                                            "additional_information": [
                                                "Estrogen receptor status is often used to determine treatment options in breast cancer."
                                            ]
                                        },
                                        {
                                            "raw_text": "progesterone receptor positive",
                                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                            "category_reasoning": "The criterion is a simple statement about the status of progesterone receptors, which can be answered with a yes or no.",
                                            "overall_thoughts": "This criterion specifies a requirement for the progesterone receptor status of the participant's cancer, which is a common eligibility criterion in hormone receptor-related cancer trials.",
                                            "root_term": "progesterone receptor",
                                            "qualifiers": [
                                                "positive"
                                            ],
                                            "relation_type": "status",
                                            "target": [
                                                {
                                                    "answer": "positive",
                                                    "dependent_criterion": null
                                                }
                                            ],
                                            "additional_information": [
                                                "This criterion is often used in breast cancer trials to identify patients whose tumors may respond to hormone therapy."
                                            ]
                                        }
                                    ]
                                },
                                "additional_information": [
                                    "This criterion is likely used to select patients who have a specific type of cancer that is hormone receptor positive, which is relevant for certain types of breast cancer."
                                ]
                            },
                            {
                                "raw_text": "Progression on prior therapy with trastuzumab if HER2-neu positive.",
                                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                                "category_reasoning": "The criterion is hierarchical because it specifies a condition (HER2-neu positive) that must be met for the main criterion (progression on prior therapy with trastuzumab) to be applicable.",
                                "overall_thoughts": "This criterion is specific to patients who have HER2-neu positive cancer and have shown progression on trastuzumab therapy. It is a common eligibility criterion in trials targeting HER2-positive cancers.",
                                "root_term": "Progression on prior therapy",
                                "qualifiers": [
                                    "with trastuzumab"
                                ],
                                "relation_type": "if",
                                "target": [
                                    {
                                        "answer": "HER2-neu positive",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "This criterion is relevant for trials focusing on HER2-positive cancers, particularly breast cancer, where trastuzumab is a common treatment."
                                ]
                            },
                            {
                                "raw_text": "If patient has progressed through hormone or trastuzumab therapy only, must have received one chemotherapy regimen.",
                                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                                "category_reasoning": "The criterion involves two separate conditions: progression through hormone or trastuzumab therapy, and having received one chemotherapy regimen. These conditions are connected by a logical dependency, making it a compound criterion.",
                                "overall_thoughts": "This criterion specifies conditions related to prior treatments a patient must have undergone, indicating a compound nature due to the logical dependency between the conditions.",
                                "logical_operator": "AND",
                                "criterions": [
                                    {
                                        "raw_text": "Patient has progressed through hormone or trastuzumab therapy only.",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion specifies a single condition regarding the patient's treatment history, which can be answered with a yes or no.",
                                        "overall_thoughts": "This criterion is straightforward, specifying that the patient must have progressed through specific therapies, namely hormone or trastuzumab therapy.",
                                        "root_term": "Patient",
                                        "qualifiers": [],
                                        "relation_type": "has progressed through",
                                        "target": [
                                            {
                                                "answer": "hormone or trastuzumab therapy only",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": [
                                            "The criterion implies that the patient should have undergone and progressed through either hormone therapy or trastuzumab therapy, but not other therapies."
                                        ]
                                    },
                                    {
                                        "raw_text": "Patient must have received one chemotherapy regimen.",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no question regarding the patient's treatment history.",
                                        "overall_thoughts": "This criterion specifies a treatment history requirement for eligibility, focusing on prior chemotherapy.",
                                        "root_term": "Patient",
                                        "qualifiers": [
                                            "must have received one chemotherapy regimen"
                                        ],
                                        "relation_type": "treatment history requirement",
                                        "target": [
                                            {
                                                "answer": "Yes",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": []
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            {
                "raw_text": "Ovarian Cancer Inclusion Criteria:\n\n* Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)\n* Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).\n* Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion is composed of multiple distinct requirements that need to be met for inclusion, each of which can be considered separately.",
                "overall_thoughts": "This is a well-structured compound criterion for a clinical trial, specifying multiple inclusion requirements for participants with ovarian cancer.",
                "logical_operator": "AND",
                "criterions": [
                    {
                        "raw_text": "Measurable metastatic disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition that can be verified: the presence of measurable metastatic disease according to RECIST guidelines.",
                        "overall_thoughts": "This criterion is straightforward as it refers to a specific and standardized method of evaluating metastatic disease, which is commonly used in clinical trials.",
                        "root_term": "metastatic disease",
                        "qualifiers": [
                            "measurable",
                            "as defined by Response Evaluation Criteria in Solid Tumors (RECIST)"
                        ],
                        "relation_type": "as defined by",
                        "target": [
                            {
                                "answer": "True",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "RECIST is a set of published rules that define when cancer patients improve ('respond'), stay the same ('stabilize'), or worsen ('progress') during treatments."
                        ]
                    },
                    {
                        "raw_text": "Primary tumor must have been diagnosed histologically as either epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (not borderline or low malignant potential epithelial carcinoma).",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition regarding the diagnosis of the primary tumor, which can be answered with a simple yes or no question about the histological diagnosis.",
                        "overall_thoughts": "This criterion specifies the types of cancer diagnoses that are acceptable for the trial, excluding certain types of epithelial carcinoma.",
                        "root_term": "Primary tumor",
                        "qualifiers": [
                            "diagnosed histologically"
                        ],
                        "relation_type": "must be",
                        "target": [
                            {
                                "answer": "epithelial ovarian cancer",
                                "dependent_criterion": null
                            },
                            {
                                "answer": "fallopian tube cancer",
                                "dependent_criterion": null
                            },
                            {
                                "answer": "primary peritoneal cancer",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "Excludes borderline or low malignant potential epithelial carcinoma"
                        ]
                    },
                    {
                        "raw_text": "Subjects must have failed at least two previous chemotherapy regimens. Paclitaxel must have been a component of one or both regimens and cisplatin or carboplatin must have been a component of one or both regimens.",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion is compound because it involves multiple conditions that need to be satisfied: failing two chemotherapy regimens, having paclitaxel in one or both regimens, and having cisplatin or carboplatin in one or both regimens.",
                        "overall_thoughts": "The criterion is clear and specifies multiple conditions that must be met regarding previous chemotherapy treatments, making it a compound criterion.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Subjects must have failed at least two previous chemotherapy regimens.",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition that can be answered with a yes or no: whether the subject has failed at least two previous chemotherapy regimens.",
                                "overall_thoughts": "This criterion is straightforward, requiring subjects to have a specific treatment history of failing two chemotherapy regimens.",
                                "root_term": "Subjects",
                                "qualifiers": [
                                    "must have failed at least two previous chemotherapy regimens"
                                ],
                                "relation_type": "condition",
                                "target": [
                                    {
                                        "answer": "failed at least two previous chemotherapy regimens",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Paclitaxel must have been a component of one or both regimens.",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single requirement regarding the inclusion of Paclitaxel in treatment regimens, which can be answered with a yes or no.",
                                "overall_thoughts": "The criterion is straightforward, requiring Paclitaxel to be part of at least one treatment regimen. It does not specify any additional conditions or dependencies.",
                                "root_term": "Paclitaxel",
                                "qualifiers": [
                                    "must have been a component"
                                ],
                                "relation_type": "inclusion",
                                "target": [
                                    {
                                        "answer": "one or both regimens",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Cisplatin or carboplatin must have been a component of one or both regimens.",
                                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                                "category_reasoning": "The criterion involves two separate conditions that can be individually assessed: whether cisplatin was a component of the regimen and whether carboplatin was a component of the regimen. These are joined by the logical operator 'OR'.",
                                "overall_thoughts": "The criterion specifies that either cisplatin or carboplatin must be included in the treatment regimens, indicating flexibility in the treatment components. This is a clear compound criterion due to the presence of two distinct options connected by 'OR'.",
                                "logical_operator": "OR",
                                "criterions": [
                                    {
                                        "raw_text": "Cisplatin must have been a component of one or both regimens.",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion specifies a single requirement regarding the inclusion of Cisplatin in treatment regimens, which can be answered with a simple yes or no.",
                                        "overall_thoughts": "The criterion is straightforward, requiring that Cisplatin be part of at least one treatment regimen. It does not specify any additional conditions or sub-criteria.",
                                        "root_term": "Cisplatin",
                                        "qualifiers": [
                                            "must have been a component of one or both regimens"
                                        ],
                                        "relation_type": "inclusion",
                                        "target": [
                                            {
                                                "answer": "Cisplatin is included in at least one regimen",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": []
                                    },
                                    {
                                        "raw_text": "Carboplatin must have been a component of one or both regimens.",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion specifies a single requirement regarding the treatment regimen, which is straightforward and does not involve multiple conditions or hierarchical dependencies.",
                                        "overall_thoughts": "The criterion is clear and specifies that Carboplatin should be part of the treatment regimen, either in one or both regimens, making it a simple, atomic criterion.",
                                        "root_term": "Carboplatin",
                                        "qualifiers": [
                                            "must have been a component",
                                            "of one or both regimens"
                                        ],
                                        "relation_type": "component of",
                                        "target": [
                                            {
                                                "answer": "one or both regimens",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": []
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            {
                "raw_text": "Measurable metastatic disease AND Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion is composed of two separate conditions that need to be met: having measurable metastatic disease and having a specific type of endometrial cancer that meets additional conditions. These are joined by an AND operator, indicating that both conditions must be satisfied.",
                "overall_thoughts": "The criterion is clearly a compound criterion as it involves multiple conditions that need to be satisfied for inclusion in the trial. The use of 'AND' indicates that all listed conditions must be met.",
                "logical_operator": "AND",
                "criterions": [
                    {
                        "raw_text": "Measurable metastatic disease",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no regarding the presence of measurable metastatic disease.",
                        "overall_thoughts": "This criterion is clear and specific, focusing on the presence of measurable metastatic disease, which is a common requirement in clinical trials to assess treatment efficacy.",
                        "root_term": "metastatic disease",
                        "qualifiers": [
                            "measurable"
                        ],
                        "relation_type": "presence",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion is compound because it includes two separate conditions that must be met: 1) the cancer must be histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy, and 2) the cancer must have failed 2 previous treatment regimens. These are distinct criteria that are joined by the logical operator AND.",
                        "overall_thoughts": "This criterion is well-structured for a clinical trial as it clearly defines the patient population by specifying both the type of cancer and the treatment history required for eligibility.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Histologically proven recurrent or persistent endometrial cancer that is not amenable to curative treatment with surgery and/or radiation therapy",
                                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                                "category_reasoning": "The criterion involves multiple conditions: the cancer must be histologically proven, it must be recurrent or persistent, and it must not be amenable to curative treatment with surgery and/or radiation therapy. These conditions can be separated into distinct questions, making it a compound criterion.",
                                "overall_thoughts": "This criterion is well-structured for determining eligibility based on the status and treatment options of endometrial cancer. It clearly outlines the conditions under which a patient would qualify for the trial.",
                                "logical_operator": "AND",
                                "criterions": [
                                    {
                                        "raw_text": "Histologically proven recurrent or persistent endometrial cancer",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion specifies a single condition that can be verified through a histological examination, making it an atomic criterion.",
                                        "overall_thoughts": "This criterion is straightforward, requiring histological proof of recurrent or persistent endometrial cancer.",
                                        "root_term": "endometrial cancer",
                                        "qualifiers": [
                                            "histologically proven",
                                            "recurrent",
                                            "persistent"
                                        ],
                                        "relation_type": "condition",
                                        "target": [
                                            {
                                                "answer": "true",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": []
                                    },
                                    {
                                        "raw_text": "Not amenable to curative treatment with surgery and/or radiation therapy",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion is a single statement that can be answered with a yes or no regarding the patient's condition in relation to curative treatment options.",
                                        "overall_thoughts": "This criterion specifies that the patient should not be suitable for curative treatment using surgery or radiation therapy, indicating a more advanced or unsuitable stage of disease for these treatments.",
                                        "root_term": "amenable to curative treatment",
                                        "qualifiers": [
                                            "not",
                                            "with surgery and/or radiation therapy"
                                        ],
                                        "relation_type": "not amenable to",
                                        "target": [
                                            {
                                                "answer": "false",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": [
                                            "This criterion is often used to identify patients who may require alternative or palliative treatment options."
                                        ]
                                    }
                                ]
                            },
                            {
                                "raw_text": "Has failed 2 previous treatment regimens",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, based on the patient's treatment history.",
                                "overall_thoughts": "This criterion is clear and specific, focusing on the patient's history with treatment regimens.",
                                "root_term": "treatment regimens",
                                "qualifiers": [
                                    "failed",
                                    "2 previous"
                                ],
                                "relation_type": "has failed",
                                "target": [
                                    {
                                        "answer": "Yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            }
                        ]
                    }
                ]
            },
            {
                "raw_text": "Measurable metastatic disease AND Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy AND has failed 2 previous treatment regimens.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion is compound because it includes multiple conditions that need to be satisfied: having measurable metastatic disease and having a specific type of cervical cancer that is not amenable to curative treatment and has failed 2 previous treatment regimens.",
                "overall_thoughts": "The criterion is well-structured and specifies multiple conditions that must be met for inclusion, making it a compound criterion. It clearly outlines the type of cancer, treatment history, and disease status required for eligibility.",
                "logical_operator": "AND",
                "criterions": [
                    {
                        "raw_text": "Measurable metastatic disease",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no regarding the presence of measurable metastatic disease.",
                        "overall_thoughts": "This criterion is clear and specific, focusing on the presence of measurable metastatic disease, which is a common requirement in clinical trials to assess treatment efficacy.",
                        "root_term": "disease",
                        "qualifiers": [
                            "measurable",
                            "metastatic"
                        ],
                        "relation_type": "presence",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Histologically proven recurrent or persistent squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix that is not amenable to curative treatment with surgery and/or radiation therapy",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition regarding the type and status of cervical cancer that cannot be treated with curative intent using surgery or radiation therapy.",
                        "overall_thoughts": "This criterion is specific to patients with certain types of cervical cancer that have recurred or persisted and are not treatable with curative surgery or radiation.",
                        "root_term": "cervical cancer",
                        "qualifiers": [
                            "histologically proven",
                            "recurrent",
                            "persistent",
                            "squamous cell carcinoma",
                            "adenosquamous carcinoma",
                            "adenocarcinoma",
                            "not amenable to curative treatment with surgery and/or radiation therapy"
                        ],
                        "relation_type": "is",
                        "target": [
                            {
                                "answer": "true",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "The criterion focuses on the histological confirmation and treatment limitations of the cancer."
                        ]
                    },
                    {
                        "raw_text": "Has failed 2 previous treatment regimens",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, based on the patient's treatment history.",
                        "overall_thoughts": "This criterion is clear and specific, focusing on the patient's treatment history and failure to respond to previous regimens.",
                        "root_term": "treatment regimens",
                        "qualifiers": [
                            "failed",
                            "2 previous"
                        ],
                        "relation_type": "has failed",
                        "target": [
                            {
                                "answer": "Yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    }
                ]
            },
            {
                "raw_text": "Exclusion Criteria:\n\n* Had/have the following prior/concurrent therapy:\n\n  * Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)\n  * Investigational drugs/agents within 14 days of first dose of 852A\n  * Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)\n  * Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions\n  * Radiotherapy within 3 weeks of the first dose of 852A\n  * Hematopoietic cell transplantation within 4 weeks of first dose of 852A\n  * Evidence of active infection within 3 days of first dose of 852A\n  * Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)\n  * Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication\n  * History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk\n  * Uncontrolled intercurrent or chronic illness\n  * Active autoimmune disease requiring immunosuppressive therapy within 30 days\n  * Active coagulation disorder not controlled with medication\n  * Pregnant or lactating\n  * Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated\n  * Any history of brain metastases or any other active central nervous system (CNS) disease",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion lists multiple exclusion conditions that are distinct and can be separated into individual questions regarding prior/concurrent therapies, medical conditions, and other health-related factors.",
                "overall_thoughts": "This exclusion criterion is comprehensive, covering a wide range of prior treatments and medical conditions that could impact the study's outcomes or participant safety. Each bullet point represents a separate exclusion condition.",
                "logical_operator": "OR",
                "criterions": [
                    {
                        "raw_text": "Systemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed)",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition regarding the use of systemic corticosteroids within a specific timeframe, which can be answered with a yes or no.",
                        "overall_thoughts": "The criterion is clear in specifying the exclusion of systemic corticosteroids within a certain timeframe, while allowing topical or inhaled steroids.",
                        "root_term": "Systemic corticosteroids",
                        "qualifiers": [
                            "oral or injectable",
                            "within 7 days of first dose of 852A"
                        ],
                        "relation_type": "exclusion",
                        "target": [
                            {
                                "answer": "not allowed",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "topical or inhaled steroids are allowed"
                        ]
                    },
                    {
                        "raw_text": "Investigational drugs/agents within 14 days of first dose of 852A",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition regarding the use of investigational drugs/agents within a specific timeframe relative to the first dose of 852A.",
                        "overall_thoughts": "This criterion is straightforward, specifying a restriction on the use of investigational drugs or agents within a 14-day period before the first dose of the study drug 852A.",
                        "root_term": "Investigational drugs/agents",
                        "qualifiers": [
                            "within 14 days of first dose of 852A"
                        ],
                        "relation_type": "prohibited",
                        "target": [
                            {
                                "answer": "No",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A (nitrosoureas within 30 days of first dose)",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions related to immunosuppressive therapy: one for cytotoxic agents and another for nitrosoureas, each with different time frames. This makes it a compound criterion as it combines multiple conditions.",
                        "overall_thoughts": "The criterion specifies exclusion based on recent use of immunosuppressive therapy, with specific time frames for different types of agents, indicating a need to assess both conditions separately.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Immunosuppressive therapy, including cytotoxic agents within 14 days of first dose of 852A",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition regarding the use of immunosuppressive therapy, including cytotoxic agents, within a specific timeframe before the first dose of the trial drug.",
                                "overall_thoughts": "This criterion is straightforward, specifying a restriction on prior treatment with immunosuppressive therapy, including cytotoxic agents, within a 14-day window before the first dose of the trial drug 852A.",
                                "root_term": "Immunosuppressive therapy",
                                "qualifiers": [
                                    "including cytotoxic agents",
                                    "within 14 days of first dose of 852A"
                                ],
                                "relation_type": "prohibited",
                                "target": [
                                    {
                                        "answer": "use",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "This criterion is likely intended to ensure that participants do not have residual effects from recent immunosuppressive therapy that could confound the trial results."
                                ]
                            },
                            {
                                "raw_text": "Nitrosoureas within 30 days of first dose of 852A",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition regarding the use of nitrosoureas within a specific timeframe relative to the first dose of 852A.",
                                "overall_thoughts": "This criterion is straightforward, specifying a restriction on the use of nitrosoureas within a certain timeframe before the first dose of the trial drug 852A.",
                                "root_term": "Nitrosoureas",
                                "qualifiers": [
                                    "within 30 days of first dose of 852A"
                                ],
                                "relation_type": "temporal restriction",
                                "target": [
                                    {
                                        "answer": "not allowed",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            }
                        ]
                    },
                    {
                        "raw_text": "Drugs known to induce QT interval prolongation and/or induce Torsades de pointes unless best available drug required to treat life-threatening conditions",
                        "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                        "category_reasoning": "The criterion specifies a condition related to the use of certain drugs (those that induce QT interval prolongation or Torsades de pointes) and adds an exception (unless the drug is required to treat life-threatening conditions). This structure indicates a hierarchical relationship where the child criterion modifies the parent criterion.",
                        "overall_thoughts": "This criterion is concerned with the safety of drug use in the context of clinical trials, specifically focusing on the risk of QT interval prolongation and Torsades de pointes. The exception clause allows for flexibility in cases where the drug is necessary for treating life-threatening conditions, highlighting a balance between risk and necessity.",
                        "parent_criterion": {
                            "raw_text": "Drugs known to induce QT interval prolongation and/or induce Torsades de pointes",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is focused on a specific characteristic of drugs, namely their potential to induce QT interval prolongation or Torsades de pointes, which can be answered with a simple yes or no.",
                            "overall_thoughts": "This criterion is concerned with the exclusion of drugs that have known effects on cardiac electrophysiology, specifically those that can prolong the QT interval or cause Torsades de pointes.",
                            "root_term": "Drugs",
                            "qualifiers": [
                                "known to induce QT interval prolongation",
                                "induce Torsades de pointes"
                            ],
                            "relation_type": "exclusion",
                            "target": [
                                {
                                    "answer": "No",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "QT interval prolongation is a measure of delayed ventricular repolarization, which can lead to arrhythmias.",
                                "Torsades de pointes is a specific type of abnormal heart rhythm that can be life-threatening."
                            ]
                        },
                        "child_criterion": null,
                        "additional_information": [
                            "QT interval prolongation and Torsades de pointes are serious cardiac conditions that can be induced by certain medications.",
                            "The criterion allows for exceptions when the drug is necessary for treating life-threatening conditions, indicating a risk-benefit assessment."
                        ]
                    },
                    {
                        "raw_text": "Radiotherapy within 3 weeks of the first dose of 852A",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, based on whether the patient received radiotherapy within the specified timeframe.",
                        "overall_thoughts": "This criterion is checking for recent radiotherapy treatment relative to the administration of the trial drug 852A, which could be important for safety or efficacy reasons.",
                        "root_term": "Radiotherapy",
                        "qualifiers": [
                            "within 3 weeks of the first dose of 852A"
                        ],
                        "relation_type": "temporal",
                        "target": [
                            {
                                "answer": "Yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "This criterion likely aims to exclude patients who have had recent radiotherapy, as it may interfere with the trial treatment or affect patient safety."
                        ]
                    },
                    {
                        "raw_text": "Hematopoietic cell transplantation within 4 weeks of first dose of 852A",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion specifies a single condition related to the timing of a medical procedure (hematopoietic cell transplantation) relative to the administration of a drug (852A).",
                        "overall_thoughts": "This criterion is straightforward, specifying a time-based exclusion related to a specific medical procedure and treatment.",
                        "root_term": "Hematopoietic cell transplantation",
                        "qualifiers": [
                            "within 4 weeks of first dose of 852A"
                        ],
                        "relation_type": "temporal",
                        "target": [
                            {
                                "answer": "true",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Evidence of active infection within 3 days of first dose of 852A",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a straightforward requirement that can be answered with a yes or no regarding the presence of an active infection within a specified timeframe.",
                        "overall_thoughts": "This criterion is clear and specific, focusing on the presence of an active infection within a short timeframe relative to the administration of the first dose of the drug 852A.",
                        "root_term": "active infection",
                        "qualifiers": [
                            "evidence",
                            "within 3 days of first dose of 852A"
                        ],
                        "relation_type": "temporal",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "The criterion specifies a timeframe of 3 days relative to the first dose of 852A, indicating a concern for infections that could interfere with the treatment or its assessment."
                        ]
                    },
                    {
                        "raw_text": "Active fungal infection or pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: 'active fungal infection' and 'pulmonary infiltrates'. These are joined by the logical operator 'or', indicating that either condition would meet the criterion. Additionally, there is a parenthetical note that provides further specification for cases of prior treated disease, which adds complexity but does not change the fundamental compound nature of the criterion.",
                        "overall_thoughts": "This criterion is compound because it involves two distinct medical conditions that are considered separately. The parenthetical note provides additional context for interpretation but does not alter the compound nature of the criterion.",
                        "logical_operator": "OR",
                        "criterions": [
                            {
                                "raw_text": "Active fungal infection",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no regarding the presence of an active fungal infection.",
                                "overall_thoughts": "This criterion is clear and specific, focusing on the presence of an active fungal infection.",
                                "root_term": "fungal infection",
                                "qualifiers": [
                                    "active"
                                ],
                                "relation_type": "presence",
                                "target": [
                                    {
                                        "answer": "yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Pulmonary infiltrates (prior treated disease stable for 2 weeks is allowable)",
                                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                                "category_reasoning": "The criterion consists of a main condition (pulmonary infiltrates) and an additional condition that modifies the main one (prior treated disease stable for 2 weeks is allowable). This structure indicates a hierarchical relationship where the child criterion provides an exception or additional context to the parent criterion.",
                                "overall_thoughts": "The criterion is structured to first identify patients with pulmonary infiltrates and then allows for an exception if the infiltrates are due to a previously treated disease that has been stable for at least two weeks. This hierarchical structure is common in clinical trial criteria to allow for specific exceptions or modifications to a general rule.",
                                "parent_criterion": {
                                    "raw_text": "Pulmonary infiltrates",
                                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                    "category_reasoning": "The criterion is a simple statement that can be answered with a yes or no regarding the presence of pulmonary infiltrates.",
                                    "overall_thoughts": "This criterion is straightforward and focuses on the presence of pulmonary infiltrates, which is a common clinical finding.",
                                    "root_term": "Pulmonary infiltrates",
                                    "qualifiers": [],
                                    "relation_type": "presence",
                                    "target": [
                                        {
                                            "answer": "yes",
                                            "dependent_criterion": null
                                        }
                                    ],
                                    "additional_information": []
                                },
                                "child_criterion": {
                                    "raw_text": "prior treated disease stable for 2 weeks is allowable",
                                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                    "category_reasoning": "The criterion specifies a single condition regarding the stability of a previously treated disease for a specific duration, which can be answered with a simple yes or no.",
                                    "overall_thoughts": "This criterion is straightforward, specifying that a previously treated disease must have been stable for at least 2 weeks to be considered allowable for the trial.",
                                    "root_term": "disease",
                                    "qualifiers": [
                                        "prior treated",
                                        "stable for 2 weeks"
                                    ],
                                    "relation_type": "allowable",
                                    "target": [
                                        {
                                            "answer": "yes",
                                            "dependent_criterion": null
                                        }
                                    ],
                                    "additional_information": []
                                },
                                "additional_information": [
                                    "Pulmonary infiltrates refer to substances denser than air, such as pus, blood, or protein, which lingers within the parenchyma of the lungs.",
                                    "The criterion allows for patients with pulmonary infiltrates if the condition has been stable for at least two weeks after treatment, indicating a focus on stability and recent treatment history."
                                ]
                            }
                        ]
                    },
                    {
                        "raw_text": "Cardiac ischemia, cardiac arrhythmias or congestive heart failure uncontrolled by medication",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion lists multiple cardiac conditions (ischemia, arrhythmias, and congestive heart failure) that are uncontrolled by medication, connected by the logical operator 'or'. This makes it a compound criterion as it involves multiple conditions that can be individually assessed.",
                        "overall_thoughts": "The criterion is clear in specifying that any of the listed cardiac conditions, if uncontrolled by medication, would make a patient ineligible. The use of 'or' indicates that the presence of any one of these conditions is sufficient for exclusion.",
                        "logical_operator": "OR",
                        "criterions": [
                            {
                                "raw_text": "Cardiac ischemia uncontrolled by medication",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a single condition that can be assessed with a straightforward question about the patient's medical status.",
                                "overall_thoughts": "This criterion specifies a condition related to cardiac health that must be uncontrolled by medication, which is a clear and specific requirement for trial eligibility.",
                                "root_term": "Cardiac ischemia",
                                "qualifiers": [
                                    "uncontrolled by medication"
                                ],
                                "relation_type": "condition",
                                "target": [
                                    {
                                        "answer": "uncontrolled by medication",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Cardiac arrhythmias uncontrolled by medication",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a single condition that can be assessed with a straightforward question about the patient's cardiac arrhythmia status and its control by medication.",
                                "overall_thoughts": "This criterion is clear and specific, focusing on the control status of cardiac arrhythmias with medication.",
                                "root_term": "Cardiac arrhythmias",
                                "qualifiers": [
                                    "uncontrolled by medication"
                                ],
                                "relation_type": "status",
                                "target": [
                                    {
                                        "answer": "uncontrolled",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "This criterion is concerned with the effectiveness of medication in controlling cardiac arrhythmias."
                                ]
                            },
                            {
                                "raw_text": "Congestive heart failure uncontrolled by medication",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a single condition that can be assessed with a straightforward question about the patient's medical status.",
                                "overall_thoughts": "This criterion specifies a medical condition that must be uncontrolled by medication, which is a clear and specific requirement for trial eligibility.",
                                "root_term": "Congestive heart failure",
                                "qualifiers": [
                                    "uncontrolled by medication"
                                ],
                                "relation_type": "condition",
                                "target": [
                                    {
                                        "answer": "uncontrolled by medication",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            }
                        ]
                    },
                    {
                        "raw_text": "History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study or put the subject at undue risk",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: one that could confound the results of the study and another that could put the subject at undue risk. These are joined by the logical operator 'OR', indicating a compound criterion.",
                        "overall_thoughts": "This criterion is designed to exclude participants who have conditions that might interfere with the study's outcomes or pose a risk to the participant. It is a compound criterion because it involves two distinct conditions that are evaluated separately.",
                        "logical_operator": "OR",
                        "criterions": [
                            {
                                "raw_text": "History of, or clinical evidence of, a condition which, in the opinion of the investigator, could confound the results of the study",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a single statement that can be answered with a yes or no regarding the presence of a condition that could confound study results.",
                                "overall_thoughts": "This criterion is designed to exclude participants who have conditions that might interfere with the study's outcomes, as determined by the investigator's judgment.",
                                "root_term": "condition",
                                "qualifiers": [
                                    "history of",
                                    "clinical evidence of"
                                ],
                                "relation_type": "could confound",
                                "target": [
                                    {
                                        "answer": "the results of the study",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "The investigator's opinion is crucial in determining if a condition could confound the study results."
                                ]
                            },
                            {
                                "raw_text": "History of, or clinical evidence of, a condition which, in the opinion of the investigator, could put the subject at undue risk",
                                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                                "category_reasoning": "The criterion involves two separate conditions: having a history of a condition or having clinical evidence of a condition. Both are evaluated by the investigator to determine if they could put the subject at undue risk. This makes it a compound criterion as it involves multiple conditions that need to be assessed.",
                                "overall_thoughts": "This criterion is designed to ensure patient safety by allowing the investigator to exclude subjects who may be at risk due to their medical history or current clinical evidence of a condition. It is compound because it involves assessing both historical and current clinical evidence.",
                                "logical_operator": "OR",
                                "criterions": [
                                    {
                                        "raw_text": "History of a condition which, in the opinion of the investigator, could put the subject at undue risk",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion is a single condition that can be evaluated with a yes or no answer based on the investigator's opinion.",
                                        "overall_thoughts": "This criterion is subjective and relies on the investigator's judgment to determine if a participant's medical history could pose a risk.",
                                        "root_term": "condition",
                                        "qualifiers": [
                                            "history of",
                                            "which, in the opinion of the investigator, could put the subject at undue risk"
                                        ],
                                        "relation_type": "could put at risk",
                                        "target": [
                                            {
                                                "answer": "undue risk",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": [
                                            "The criterion is subjective and relies on the investigator's judgment."
                                        ]
                                    },
                                    {
                                        "raw_text": "Clinical evidence of a condition which, in the opinion of the investigator, could put the subject at undue risk",
                                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                        "category_reasoning": "The criterion is a single condition that needs to be evaluated by the investigator, making it an atomic criterion.",
                                        "overall_thoughts": "This criterion requires the investigator's judgment to determine if a condition poses an undue risk to the subject, which is a common type of exclusion criterion in clinical trials.",
                                        "root_term": "condition",
                                        "qualifiers": [
                                            "clinical evidence",
                                            "in the opinion of the investigator"
                                        ],
                                        "relation_type": "could put at undue risk",
                                        "target": [
                                            {
                                                "answer": "true",
                                                "dependent_criterion": null
                                            }
                                        ],
                                        "additional_information": [
                                            "The criterion relies on the investigator's clinical judgment to assess risk."
                                        ]
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "raw_text": "Uncontrolled intercurrent or chronic illness",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: 'uncontrolled intercurrent illness' and 'chronic illness'. These can be considered as separate criteria that are joined by the logical operator 'OR'.",
                        "overall_thoughts": "The criterion is clear in specifying that either an uncontrolled intercurrent illness or a chronic illness would make a participant ineligible. This is a common type of exclusion criterion in clinical trials to ensure participant safety and data integrity.",
                        "logical_operator": "OR",
                        "criterions": [
                            {
                                "raw_text": "Uncontrolled intercurrent illness",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward exclusion based on the presence of an uncontrolled intercurrent illness, which can be answered with a yes or no.",
                                "overall_thoughts": "This criterion is commonly used to exclude participants who may have other health conditions that could interfere with the study or pose additional risks.",
                                "root_term": "intercurrent illness",
                                "qualifiers": [
                                    "uncontrolled"
                                ],
                                "relation_type": "exclusion",
                                "target": [
                                    {
                                        "answer": "yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "Intercurrent illnesses are those that occur during the course of a study and are not related to the condition being studied."
                                ]
                            },
                            null
                        ]
                    },
                    {
                        "raw_text": "Active autoimmune disease requiring immunosuppressive therapy within 30 days",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a single condition that can be answered with a yes or no question regarding the presence of an active autoimmune disease requiring recent immunosuppressive therapy.",
                        "overall_thoughts": "This criterion is straightforward, focusing on the presence of an active autoimmune disease that necessitates immunosuppressive therapy within a specific timeframe.",
                        "root_term": "autoimmune disease",
                        "qualifiers": [
                            "active",
                            "requiring immunosuppressive therapy within 30 days"
                        ],
                        "relation_type": "requires",
                        "target": [
                            {
                                "answer": "yes",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": []
                    },
                    {
                        "raw_text": "Active coagulation disorder not controlled with medication",
                        "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                        "category_reasoning": "The criterion is a single condition that can be assessed with a straightforward question about the patient's medical status regarding coagulation disorders and their control with medication.",
                        "overall_thoughts": "This criterion is clear and specific, focusing on the presence of an active coagulation disorder that is not managed by medication.",
                        "root_term": "coagulation disorder",
                        "qualifiers": [
                            "active",
                            "not controlled with medication"
                        ],
                        "relation_type": "not controlled",
                        "target": [
                            {
                                "answer": "active coagulation disorder not controlled with medication",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "This criterion is likely used to exclude patients whose coagulation disorders pose a risk during the trial due to lack of control by medication."
                        ]
                    },
                    {
                        "raw_text": "Pregnant or lactating",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: being pregnant and lactating, which can be considered independently.",
                        "overall_thoughts": "The criterion is straightforward, involving two distinct conditions that are often considered in clinical trials due to potential risks or effects on the study outcomes.",
                        "root_term": "Pregnant",
                        "qualifiers": [],
                        "relation_type": "or",
                        "target": [
                            {
                                "answer": "Yes",
                                "dependent_criterion": null
                            },
                            {
                                "answer": "Lactating",
                                "dependent_criterion": null
                            }
                        ],
                        "additional_information": [
                            "Pregnancy and lactation are often exclusion criteria in clinical trials due to potential risks to the fetus or infant."
                        ]
                    },
                    {
                        "raw_text": "Concurrent malignancy (if in remission, at least 5 years disease free) except for localized (in-situ) disease, basal carcinomas and cutaneous squamous cell carcinomas that have been adequately treated",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves multiple conditions regarding concurrent malignancy, remission status, and exceptions for certain types of cancers, which can be broken down into separate questions.",
                        "overall_thoughts": "This criterion is complex as it involves multiple conditions related to concurrent malignancies, remission status, and exceptions for specific cancer types. It is important to ensure that each condition is clearly understood and evaluated separately.",
                        "logical_operator": "AND",
                        "criterions": [
                            {
                                "raw_text": "Concurrent malignancy",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward statement about the presence of another malignancy, which can be answered with a yes or no.",
                                "overall_thoughts": "This criterion is checking for the presence of another malignancy at the same time as the primary condition being studied in the trial.",
                                "root_term": "malignancy",
                                "qualifiers": [
                                    "concurrent"
                                ],
                                "relation_type": "presence",
                                "target": [
                                    {
                                        "answer": "yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "If in remission, at least 5 years disease free",
                                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                                "category_reasoning": "The criterion is hierarchical because it has a condition (being in remission) and an additional requirement (at least 5 years disease free) that applies if the condition is met.",
                                "overall_thoughts": "This criterion is structured to first check if the patient is in remission, and if so, further checks if they have been disease free for at least 5 years. It is a clear example of a hierarchical criterion.",
                                "parent_criterion": {
                                    "raw_text": "If in remission",
                                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                    "category_reasoning": "The criterion is a simple statement that can be answered with a yes or no, making it an atomic criterion.",
                                    "overall_thoughts": "The criterion is straightforward, indicating a condition of remission without additional qualifiers or conditions.",
                                    "root_term": "remission",
                                    "qualifiers": [],
                                    "relation_type": "state",
                                    "target": [
                                        {
                                            "answer": "yes",
                                            "dependent_criterion": null
                                        }
                                    ],
                                    "additional_information": []
                                },
                                "child_criterion": {
                                    "raw_text": "at least 5 years disease free",
                                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                    "category_reasoning": "The criterion is a straightforward requirement that can be answered with a yes or no, based on the patient's disease-free duration.",
                                    "overall_thoughts": "This criterion specifies a minimum duration of being disease-free, which is a common requirement in clinical trials to ensure patient stability.",
                                    "root_term": "disease free",
                                    "qualifiers": [
                                        "at least 5 years"
                                    ],
                                    "relation_type": "duration",
                                    "target": [
                                        {
                                            "answer": "true",
                                            "dependent_criterion": null
                                        }
                                    ],
                                    "additional_information": []
                                },
                                "additional_information": [
                                    "The criterion is likely used to ensure long-term remission before considering a patient eligible for the trial."
                                ]
                            },
                            {
                                "raw_text": "Except for localized (in-situ) disease",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition that can be answered with a yes or no question regarding the presence of localized (in-situ) disease.",
                                "overall_thoughts": "This criterion excludes patients with localized (in-situ) disease from the study, indicating that the trial is likely focused on more advanced stages of disease.",
                                "root_term": "disease",
                                "qualifiers": [
                                    "localized (in-situ)"
                                ],
                                "relation_type": "exclusion",
                                "target": [
                                    {
                                        "answer": "no",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Except for basal carcinomas that have been adequately treated",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition regarding basal carcinomas, which can be answered with a simple yes or no question about whether the basal carcinomas have been adequately treated.",
                                "overall_thoughts": "This criterion excludes patients with basal carcinomas unless they have been adequately treated, indicating a specific condition under which basal carcinomas are acceptable.",
                                "root_term": "basal carcinomas",
                                "qualifiers": [
                                    "adequately treated"
                                ],
                                "relation_type": "exception",
                                "target": [
                                    {
                                        "answer": "adequately treated",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Except for cutaneous squamous cell carcinomas that have been adequately treated",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion specifies a single condition regarding the treatment status of cutaneous squamous cell carcinomas, which can be answered with a simple yes or no.",
                                "overall_thoughts": "This criterion excludes patients with cutaneous squamous cell carcinomas unless they have been adequately treated, indicating a focus on ensuring that only patients with resolved or managed conditions are included.",
                                "root_term": "cutaneous squamous cell carcinomas",
                                "qualifiers": [
                                    "adequately treated"
                                ],
                                "relation_type": "except for",
                                "target": [
                                    {
                                        "answer": "adequately treated",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            }
                        ]
                    },
                    {
                        "raw_text": "Any history of brain metastases or any other active central nervous system (CNS) disease",
                        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                        "category_reasoning": "The criterion involves two separate conditions: history of brain metastases and any other active CNS disease, connected by the logical operator 'or'. This makes it a compound criterion.",
                        "overall_thoughts": "The criterion is clear in specifying two distinct conditions that would affect eligibility, making it a compound criterion due to the use of 'or'.",
                        "logical_operator": "OR",
                        "criterions": [
                            {
                                "raw_text": "Any history of brain metastases",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward question about the patient's medical history regarding brain metastases.",
                                "overall_thoughts": "This criterion is clear and specific, focusing on the patient's history of brain metastases.",
                                "root_term": "brain metastases",
                                "qualifiers": [
                                    "history"
                                ],
                                "relation_type": "history of",
                                "target": [
                                    {
                                        "answer": "yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": []
                            },
                            {
                                "raw_text": "Any other active central nervous system (CNS) disease",
                                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                                "category_reasoning": "The criterion is a straightforward exclusion based on the presence of any active CNS disease, which can be answered with a yes or no.",
                                "overall_thoughts": "This criterion is used to exclude participants with active CNS diseases, which could interfere with the trial or the interpretation of its results.",
                                "root_term": "central nervous system disease",
                                "qualifiers": [
                                    "any other",
                                    "active"
                                ],
                                "relation_type": "presence",
                                "target": [
                                    {
                                        "answer": "yes",
                                        "dependent_criterion": null
                                    }
                                ],
                                "additional_information": [
                                    "The criterion implies exclusion if the participant has any active CNS disease other than those already specified in the trial."
                                ]
                            }
                        ]
                    }
                ]
            }
        ]
    }
}